Add Comment on:
INDIA: Stand strong against harmful provisions of EU-India free trade agreement
Harmful intellectual property (IP) provisions in the FTA that will hinder access to quality, affordable generic medicines produced in India, which have played a crucial role in scaling up HIV treatment to more than 6.6 million people across Asia, Africa and Latin America.
Harmful intellectual property (IP) provisions in the FTA that will hinder access to quality, affordable generic medicines produced in India, which have played a crucial role in scaling up HIV treatment to more than 6.6 million people across Asia, Africa and Latin America.
×
Previews not available for media files.
Short description of the image used by screen readers.
Guidelines for commenting on news articles:
Thanks for contributing to Indybay's open publishing newswire. You may use any format for your response, from traditional academic discourse to subjective personal account. Please, keep it on topic and concise. Read our editorial policy, privacy, and legal statements before continuing. Or go back to the article.